Infectious complications of bio-alcamid filler used for HIV-related facial lipoatrophy

Clinical Infectious Diseases

Volumn 55, Issue 11, 2012, Pages 1568-1574

  Nadarajah, Jeya T ^a,b   Collins, Micaela ^a   Raboud, Janet ^a,b   Su, Desheng ^a   Rao, Kavya ^a   Loutfy, Mona R ^b,c   Walmsley, Sharon ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIO ALCAMID; FILLER; UNCLASSIFIED DRUG;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; DENTAL PROCEDURE; DISEASE SEVERITY; ENTEROBACTERIACEAE INFECTION; ESTHETIC SURGERY; FACE INJURY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS RELATED FACIAL LIPOATROPHY; IMMUNE DEFICIENCY; INCIDENCE; LIPOATROPHY; MAJOR CLINICAL STUDY; MALE; MANIPULATIVE MEDICINE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; OUTCOME ASSESSMENT; PRIMARY INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; SURGICAL DRAINAGE;

ACRYLIC RESINS; ANTI-HIV AGENTS; BACTERIAL INFECTIONS; FACE; FEMALE; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; NIACINAMIDE; PIPERAZINES; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 84869015367     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis745     Document Type: Article

References (39)

1. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidemia, and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998; 12:51-8.
2. Heath K, Hogg RS, Chan K, et al. Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a populationbased HIV/AIDS treatment database. AIDS 2001; 15:231-9.
3. Lichtenstein KA, Ward DJ, Moorman AC, et al. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS 2001; 15:1389-98.
4. Carrieri P, Cailleton V, Le Moing V, et al. The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort. JAIDS 2001; 28:232-9.
5. Ribera E, Paradineiro JC, Curran A, et al. Improvements in subcutaneous fat, lipid profile, and parameters of mitochondrial toxicity in patients with peripheral lipoatrophy when stavudine is switched to tenofovir (LIPOTEST) study. HIV Clin Trial 2008; 9:407-17.
6. Tebas P, Zhang J, Hafner R, et al. Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside- sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110. J Antimicrob Chemother 2009; 63:998-1005.
7. Benn P, Sauret-Jackson V, Cartledge J, et al. Improvements in cheek volume in lipoatrophic individuals switching away from thymidine nucleoside reverse transcriptase inhibitors. HIV Medicine 2009; 10:351-5.
8. Tai W, Schambelan M, Algren H, Shayevich C, Mulligan K. Effects of recombinant human growth hormone on fat redistribution in patients with human immunodeficiency virus-associated wasting. Clin Infect Dis 2002; 35:1258-62.
9. Lo JC, Mulligan K, Noor MA, et al. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation. J. Clin Endocrinol Metab 2001; 86:3480-7.
10. Carr A, Workman C, Carey D, et al. No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomized, double-blind, placebocontrolled trial. Lancet 2004; 363:429-38.
11. Guaraldi G, Fontdevila J, Christensen LH, et al. Surgical correction of HIV-associated facial lipoatrophy. AIDS 2011; 25:1-12.
12. Formigli L, Zecchi S, Protopapa C. Bio-Alcamid: an electron microscopic study after skin implantation. Plas Recon Surg 2004; 113:1104-6.
13. Pacini S, Ruggiero M, Morucci G, Cammarota N, Protopapa C, Gulisano M. Bio-Alcamid: a novelty for reconstructive and cosmetic surgery. Int J Anat Embryol 2002; 107:209-214.
14. Protopapa C, Sito G, Caporale D. Bio-Alcamid in drug-induced lipodystrophy. J Cosmet Laser Ther 2003; 5:226-30.
15. Honig JF. Cheek augmentation with Bio-Alcamid in facial lipoatrophy in HIV seropositive patients. J Craniofac Surg 2008; 19:1085-8.
16. Lahiri A, Waters R. Experience with Bio-Alcamid, a new soft tissue endoprosthesis. JPRAS 2007; 60:663-7.
17. Ramon Y, Lucian F, Ullman Y. Preliminary experiences with Bio- Alcamid in HIV facial lipoatrophy. Dermatology 2007; 214:151-4.
18. Treacy PJ, Goldberg DJ. Use of a biopolymer polyalkylimide filler for facial lipodystrophy in HIV-positive patients undergoing treatment with antiretroviral drugs. Dermatol Surg 2006; 32:804-8.
19. Antoniou T, Raboud J, Kovacs C, et al. Long-term efficacy and safety of polyalkylimide gel for the treatment of HIV-associated lipoatrophy. AIDS Care 2009; 21:1247-52.
20. Loutfy MR, Raboud JM, Antoniou T, et al. Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIVpositive patients. AIDS 2007; 21:1147-55.
21. Karim RB, de Lint CA, van Galen SR, et al. Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients. Aesth Plast Surg 2008; 32:873-8.
22. Jones DH, Carruthers A, Fitzgerald R, Sarantopoulos P, Binder S. Late appearing abscesses after injections of nonabsorbable hydrogel polymer for HIV-associated facial lipoatrophy. Dermatol Surg 2007; 33(suppl 1):193-8.
23. Goldan O, Georgiou I, Grabov-Nardini G, et al. Early and late complications after a nonabsorbable hydrogel polymer injection: a series of 14 patients and novel management. Dermatol Surg 2007; 33(suppl 1):199-206.
24. Nelson L, Stewart KJ. Experience in the treatment of HIV-associated lipodystrophy. JPRAS 2008; 61:366-71.
25. Nelson L, Stewart KJ. Early and late complications of polyalkylimide gel (Bio-Alcamid). J Plas Reconstr Aesth Surg 2011; 64:401-5.
26. Schelke LW, van den Elzen HJ, Canninga M, Neumann MH. Complications after treatment with polyalkylimide. Dermatol Surg 2009; 35:1625-8.
27. Valantin MA, Aubron-Olivier C, Ghosn J, et al. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS 2003; 17:2471-77.
28. Mest DR, Humble G. Safety and efficacy of intradermal poly-L-lactic acid (Sculptra) injections in patients with HIV-associated facial lipoatrophy. Antivir Ther 2004; 9:L36.
29. Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003; 29:588-95.
30. Gooderham M, Solish N. Use of hyaluronic acid for soft tissue augmentation of HIV-associated facial lipodystrophy. Dermatol Surg 2005; 31:104-8.
31. Saylan Z. Facial fillers and their complications. Aesthet Surg J 2003; 23:221-4.
32. Alcalay J, Alkalay R, Gat A, Yorav S. Late-onset granulomatous reaction to Artecoll. Dermatol Surg 2003; 20:859-62.
33. Guaraldi G, Orlando G, DeFazio D, et al. Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study. Antivir Ther 2005; 10:753-9.
34. De Santis G, Pignatti M, Baccarani A, et al. Long-term efficacy and safety of polyacrylamide hydrogel injection in the treatment of human immunodeficiency virus-related facial lipoatrophy: a 5-year follow-up. Plast Reconstr Surg 2012; 129:101-9.
35. Negredo E, Puig J, ALdea D, et al. Four-year safety with polyacrylamide hydrogel to correct antiretroviral-related facial lipoatrophy. AIDS Res Hum Retrov 2009; 25:451-5.
36. Karim RB, Hage JJ, van Rozelaar L, Lange CAH, Raaijmakers J. Complications of polyalkylimide 4% injections (Bio-Alcamid): a report of 18 cases. JPRAS 2006; 59:1409-1414.
37. Rohrich RJ, Monheit G, Nguyen AT, Brown SA, Fagien S. Soft-tissue filler complications: The important role of biofilms. Plast Reconstr Surg 2010; 125:1250-6.
38. Bjarnsholt T, Tolker-Nielson T, Givskov M, Janssen M, Christensen LH. Detection of bacteria by fluorescence in situ hybridization in culturenegative soft tissue filler lesions. Dermatol Surg 2009; 35:1620-4.
39. Wilson YL, Ellis DA. Large needle suction aspiration of permanent fillers. Laryngoscope 2011; 121:2146-9.